Emergen Research Logo
Major prevalence of neurological disorders and rapidly increasing geriatric population are key factors driving growth of the global blood-brain barrier market
— Emergen Research
VANCOUVER, BC, CANADA, April 18, 2023 /EINPresswire.com/ — The Global Blood-Brain Barrier (BBB) Market size is expected to reach USD 7.40 Billion in 2028 at a steady CAGR over the forecast period, according to latest analysis by Emergen Research. Major factors driving market revenue growth include major prevalence of neurological disorders such as Parkinson’s Disease, Alzheimer’s Disease, Hunter’s Syndrome, and brain tumors. Other factors include rising healthcare expenses and increasing investment in pharmaceutical research and development. Blood-brain barrier plays a vital role in protecting the brain from toxic compounds and many blood-borne disorders. It helps to prevent the circulation of compounds from the circulatory systems to Cerebrospinal Fluid (CSF) or brain through a particular exchange of components controlled by BBB or blood CSF barrier. This function also significantly impedes delivery of drugs to the brain. In case of central nervous system disorders, it is required to deliver drugs across this barrier and provide the appropriate therapeutic effect to the targeted location.
Ongoing technological developments in magnetic resonance imaging technology that helps to identify blood-brain barrier and introduction of advanced nanotechnology and ultrasound applications is expected to drive market revenue growth going ahead.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/633
Some Key Findings From the Report:
In January 2021, Nanoform Finland signed an agreement with Herantis Pharma. This agreement will help both companies to improve blood-brain-barrier penetration in nasal drug delivery routes for Parkinson’s therapies using nanoparticle technology.
Parkinson’s disease segment accounted for major revenue share in global market in 2020 and is expected to register a 25.1% CAGR throughout the forecast period. This is attributed to major prevalence of Parkinson’s Disease among an expanding global patient pool.
Asia Pacific is expected to register the fastest revenue CAGR throughout the forecast period, which can be attributed to rapid advancements in pharmaceutical and healthcare infrastructure, increasing aging population, major prevalence of neurological disorders, increasing number of hospitals and long-term care facilities in countries across the globe.
Top competitors of the Blood-Brain Barrier (BBB) Market profiled in the report include:
Allon Therapeutics, Inc., Angiochem Inc., Armagen Technologies, Inc., Bristol-Myers Squibb, BiOasis Technologies, Inc., Sanofi Genzyme, CarThera, Cephalon Inc., Nanomerics, and F. Hoffman La-Roche AG.
Request a discount on the report @ https://www.emergenresearch.com/request-discount/633
For the purpose of this report, Emergen Research has segmented the global blood-brain barrier (BBB) market based on application, technology, end-use, and by region:
Application Outlook (Revenue, USD Billion; 2018–2028)
Alzheimer’s Disease
Epilepsy
Parkinson’s Disease
Multiple Sclerosis
Hunter’s Syndrome
Brain Cancer
Technology Outlook (Revenue, USD Billion; 2018–2028)
Bispecific Antibody RMT Approach
Trojan Horse Approach
Increasing Permeability
Passive Diffusion
Others
End-Use Outlook (Revenue, USD Billion; 2018–2028)
Hospitals
Surgical centers
Research Institutes
Others
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/blood-brain-barrier-market
Regional Outlook (Revenue: USD Billion; 2018–2028)
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key Objectives of the Report:
Analysis and estimation of the Blood-Brain Barrier (BBB) market size and share for the projected period of 2020-2028
Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Blood-Brain Barrier (BBB) market
Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities
Explore More Emergen Research Reports @
Hematologic Malignancies Testing Market
https://www.emergenresearch.com/industry-report/hematologic-malignancies-testing-market
Occlusion Devices Market
https://www.emergenresearch.com/industry-report/occlusion-devices-market
Drip Irrigation Market
https://www.emergenresearch.com/industry-report/drip-irrigation-market
Blockchain Ai Market
https://www.emergenresearch.com/industry-report/blockchain-ai-market
Progressive Web Application Market
https://www.emergenresearch.com/industry-report/progressive-web-application-market
Marble Market
https://www.emergenresearch.com/industry-report/marble-market
Healthcare Crm Market
https://www.emergenresearch.com/industry-report/healthcare-crm-market
About Emergen Research
At Emergen Research, we believe in advancing with technology. We are a growing Marketresearch and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn
